Because about 70% of primary breast cancers are estrogen receptor-positive, hormone-sensitive tumors, posttreatment changes in the hormonal environment associated with conception or fertility preservation or both may have negative impacts on the prognosis of breast cancer. This evidence concerns the gene ESR1 and breast carcinoma.